Shareholders' Equity (Tables)

3 Months Ended

Mar. 31, 2022

Equity [Abstract]

Schedule of Stockholders' Equity

The following summarizes our shareholders’ equity activity for the three months ended March 31, 2022 and 2021:

(Dollars in millions)	Capital in Excess of Par Value		Retained Deficit		Accumulated Other Comprehensive Loss		Non-controlling Interests “NCI”		Total Shareholders’ Equity
Balance at December 31, 2021	$	2,904	$	(2,397)	$	(35)	$	24	$	496
Net Income (Loss)	—		(80)		—		6		(74)
Equity Awards, Granted, Vested and Exercised	4		—		—		—		4
Other Comprehensive Loss	—		—		—		—		—
Balance at March 31, 2022	$	2,908	$	(2,477)	$	(35)	$	30	$	426
Balance at December 31, 2020	$	2,897	$	(1,947)	$	(43)	$	30	$	937
Net Income (Loss)	—		(116)		—		6		(110)
Dividends to NCI	—		—		—		(2)		(2)
Other Comprehensive Loss	—		—		(4)		—		(4)
Balance at March 31, 2021	$	2,897	$	(2,063)	$	(47)	$	34	$	821

Schedule of Accumulated Other Comprehensive Income (Loss)

The following table presents the changes in our accumulated other comprehensive loss by component for the three months ended March 31, 2022 and 2021:

(Dollars in millions)	Currency Translation Adjustment		Defined Benefit Pension		Total
Balance at December 31, 2021	$	(36)	$	1	$	(35)
Other Comprehensive Loss	—		—		—
Balance at March 31, 2022	$	(36)	$	1	$	(35)
Balance at December 31, 2020	$	(31)	$	(12)	$	(43)
Other Comprehensive Loss	(4)		—		(4)
Balance at March 31, 2021	$	(35)	$	(12)	$	(47)